icon-folder.gif   Conference Reports for NATAP  
 
 

AASLD

The Liver Meeting
Washington DC
October 2017
Back grey_arrow_rt.gif
 
 
 
Significant anti-fibrotic efficacy of EDP-305, a highly potent and selective farnesoid X receptor (FXR) agonist, in a rat model of thioacetamide-induced liver fibrosis and cirrhosis
 
 
  Reported by Jules Levin
AASLD Annual Meeting 2017, Washington, DC, USA, October 20-24
 
Li-Juan Jiang1,*, Dipankar Bhattacharya2, Young J. Yoon2, Hsin-I Chou2, Mary Chau1, Yang Li1, Yat Sun Or1, Scott L. Friedman2
1 Enanta Pharmaceuticals, Inc., Watertown, MA, USA; 2 Icahn School of Medicine at Mount Sinai, New York, NY, USA

1120171

1120172

1120173

1120174

1120175

1120176